Epelsiban

DRUG3 trials

Sponsors

GlaxoSmithKline

Conditions

AdenomyosisEmbryo Transfer

Phase 1

A Study to Evaluate Pharmacokinetics, Pharmacodynamics and Tissue Concentrations of Epelsiban

TerminatedNCT02213029

GlaxoSmithKlineEmbryo Transfer

Start: 2014-08-28End: 2016-02-07Updated: 2017-05-08

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban in Healthy Female Volunteers

CompletedNCT02257359

GlaxoSmithKlineEmbryo Transfer

Start: 2014-12-18End: 2015-01-29Updated: 2018-09-13

Phase 2

Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis

WithdrawnNCT02794467

GlaxoSmithKlineAdenomyosis

Start: 2016-07-31End: 2016-10-31Updated: 2017-01-18